Healthcare of Ontario Pension Plan Trust Fund Purchases 326,818 Shares of Humana Inc. $HUM

Healthcare of Ontario Pension Plan Trust Fund raised its position in Humana Inc. (NYSE:HUM) by 3,350.6% during the first quarter, HoldingsChannel.com reports. The firm owned 336,572 shares of the insurance provider’s stock after purchasing an additional 326,818 shares during the period. Healthcare of Ontario Pension Plan Trust Fund’s holdings in Humana were worth $58,358,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of the business. Revolve Wealth Partners LLC bought a new stake in shares of Humana during the 4th quarter worth approximately $202,000. Woodline Partners LP grew its position in Humana by 460.0% in the 1st quarter. Woodline Partners LP now owns 10,192 shares of the insurance provider’s stock valued at $2,697,000 after acquiring an additional 8,372 shares during the last quarter. Sivia Capital Partners LLC grew its position in Humana by 53.7% in the 2nd quarter. Sivia Capital Partners LLC now owns 1,293 shares of the insurance provider’s stock valued at $316,000 after acquiring an additional 452 shares during the last quarter. Cresset Asset Management LLC increased its stake in Humana by 10.3% in the second quarter. Cresset Asset Management LLC now owns 2,369 shares of the insurance provider’s stock worth $581,000 after purchasing an additional 222 shares during the period. Finally, WINTON GROUP Ltd increased its stake in Humana by 58.5% in the second quarter. WINTON GROUP Ltd now owns 2,381 shares of the insurance provider’s stock worth $582,000 after purchasing an additional 879 shares during the period. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the stock. Deutsche Bank Aktiengesellschaft lowered shares of Humana from a “buy” rating to a “hold” rating in a research note on Wednesday, May 20th. Raymond James Financial set a $300.00 price objective on shares of Humana in a report on Tuesday, July 7th. Piper Sandler restated a “neutral” rating and issued a $254.00 target price (up from $182.00) on shares of Humana in a research note on Wednesday, May 13th. Weiss Ratings raised shares of Humana from a “hold (c-)” rating to a “hold (c)” rating in a research report on Monday, June 29th. Finally, Guggenheim raised their target price on shares of Humana from $252.00 to $269.00 and gave the stock a “buy” rating in a research report on Thursday, April 30th. Two research analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating, fifteen have assigned a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, Humana currently has an average rating of “Hold” and a consensus price target of $327.17.

Humana Stock Performance

Shares of Humana stock opened at $388.56 on Friday. The firm has a market cap of $46.65 billion, a P/E ratio of 41.56, a P/E/G ratio of 2.12 and a beta of 0.71. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.66. Humana Inc. has a 12 month low of $163.11 and a 12 month high of $428.88. The stock’s fifty day moving average price is $364.10 and its 200-day moving average price is $265.01.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share for the quarter, beating the consensus estimate of $9.97 by $0.34. Humana had a return on equity of 10.45% and a net margin of 0.82%.The firm had revenue of $39.65 billion during the quarter, compared to the consensus estimate of $39.37 billion. During the same period in the previous year, the company posted $11.58 earnings per share. The firm’s quarterly revenue was up 23.5% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000- EPS. On average, equities research analysts expect that Humana Inc. will post 9.46 earnings per share for the current fiscal year.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.